Forte Biosciences Stock Shows Unusual Price Movement Before Argenx Acquisition Announcement
Argenx (ARGX) announced its acquisition of Forte Biosciences (FBRX) at $77 per share on July 27, 2026. However, FBRX's stock began showing significant price movement as early as June 29—weeks before the official announcement. This unusual activity suggests that insider knowledge may have influenced trading behavior ahead of the deal. Both companies are focused on autoimmune disease treatments and operate in similar therapeutic areas. The acquisition is valued at $1.06 billion, with Argenx having a market capitalization of approximately $54.57 billion. Analysts noted that such pre-announcement price patterns can serve as an indicator for upcoming M&A activity. The article highlights the educational value in understanding how insider knowledge and early trading signals may precede public corporate announcements.
Topics: insider trading patterns market behavior stock price movement